Release Date: 31/07/13 15:36 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 6.27MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%